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Summary
Because hospitalized preterm infants are vulnerable to infection, they receive frequent and often 
prolonged exposures to antibiotics. It is not known if the short-term effects of antibiotics on the 
preterm infant gut microbiota and resistome persist after discharge from neonatal intensive care 
units. Here, we use complementary metagenomic, culture based, and machine learning techniques 
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to interrogate the gut microbiota and resistome of antibiotic-exposed preterm infants, during and 
after hospitalization, and compare these readouts to antibiotic-naïve healthy infants sampled 
synchronously. We find a persistently enriched gastrointestinal antibiotic resistome, prolonged 
carriage of multidrug resistant Enterobacteriaceae, and distinct antibiotic-driven patterns of 
microbiota and resistome assembly in extremely preterm infants who received early life 
antibiotics. The collateral damage of early life antibiotic treatment and hospitalization in preterm 
infants is long-lasting. We urge development of strategies to reduce these consequences in highly 
vulnerable neonatal populations.
Introduction
Gut microbes play important roles in host health and disease throughout life, particularly in 
infancy1. Infant gut microbiota (IGM) assembly accelerates in the first months of life, 
following inoculation by organisms from mothers and the environment2, but stabilizes by 
approximately three years of age3. Antibiotics in this interval may disproportionately 
damage the host-microbiota ecosystem3–5. Indeed, emerging data suggest that early-life gut 
microbial alterations correlate with chronic metabolic and immune disorders later in 
life1,4,6–16, including allergies17, psoriasis18, adiposity19, diabetes20 and inflammatory 
bowel disease21–23. For most of these disorders, a causal link between antibiotic-mediated 
microbiota disruption and onset of pathology is lacking. However, antibiotics in infancy are 
associated with permanent immune alterations18,24 and inflammatory bowel disease in 
childhood23, highlighting the damaging long-term potential of early life antibiotic treatment.
Over 11% of live births worldwide occur preterm25, and preterm birth and its sequelae are 
prominent causes of childhood morbidity and mortality worldwide26. Because bacterial 
infections are frequent complications of preterm birth27, 79% of very low birthweight and 
87% of extremely low birthweight infants in US NICUs receive antibiotics within three days 
of birth29. The gastrointestinal tracts of even healthy infants harbor a diverse antibiotic 
resistome30, which is shaped by factors including antibiotics, diet, and environment31–33. 
Preterm IGM perturbation immediately following antibiotic treatment is characterized by 
decreased alpha diversity, increased Enterobacteriaceae abundance, and antibiotic-specific 
enrichment of antibiotic resistance genes (ARGs) and multidrug resistant organisms 
(MDROs)34. Because microbiota perturbation during infancy may be disproportionately 
damaging35,36, it is imperative to study the lasting effects of antibiotics and hospitalization 
on the preterm IGM. Prior studies of preterm infants report IGM recovery concomitant with 
NICU discharge37–39. However, these studies rely on culture or amplicon sequencing (e.g. 
16S rRNA) based analysis, which focus on taxa in the microbiota rather than the functions 
they collectively encode. Here, we analyze ~1.2 terabases of metagenomic DNA from 437 
infant stools, culture and sequence 530 bacterial isolates, and functionally select 300 
gigabases of metagenomic DNA for antibiotic resistance, to investigate the long-term 
consequences of antibiotic treatment on the preterm IGM.
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Metagenomic based analysis of the effect of antibiotics on the preterm IGM
To understand the long-term effects of prematurity and associated early life hospitalization 
and antibiotic therapy on the IGM, we performed whole metagenome shotgun sequencing of 
437 fecal samples from 58 infants over the first 21 months of life (Supplementary Fig. 1; 
Supplementary Fig. 2). Our cohort included 41 preterm infants sampled in the NICU at St. 
Louis Children’s Hospital and following discharge to home. One subset of this cohort (n=9) 
received scant antibiotic therapy neonatally (each received a single concurrent course of 
gentamicin and ampicillin for <7 days). The remaining 32 preterm infants received extensive 
antibiotics over the first 21 months (median (interquartile range (IQR)) 8 courses (6,10.3) 
and 29.5 days (41.63,68.3) antibiotic therapy). All infants in this cohort were classified as 
being born preterm ((median (IQR) gestational age at birth of 26 weeks (25,27)) with very 
low birth weights (median (IQR) 840 g (770,960)). Additionally, we included 17 antibiotic-
naïve, healthy early term40 or late preterm41 (median (IQR) gestational age at birth 36 weeks 
(36,37 weeks); “near-term”) infants of the same chronological age range, sampled 
synchronously with the preterm cohort.
We inferred bacterial taxonomic composition using MetaPhlAn42. Across all infants, 
Shannon diversity increased during a developmental phase before stabilizing (Fig. 1a). In 
near-term infants, microbiota Shannon diversity increases rapidly in the first month before 
plateauing, while preterm infant microbiota diversity increases more gradually and with 
greater variation (Fig. 1a). Enterobacteriaceae and Enterococcaceae dominate the preterm 
IGM in the first months of life. In contrast, early colonization by Enterobacteriaceae in near-
term infants precedes robust colonization with Bifidobacteriaceae (Fig. 1b; Supplementary 
Fig. 3). Enterococcaceae is significantly less abundant early in life (<4 months chronological 
age) in near-term compared to preterm infants (p<0.001, Wilcoxon), and Prevotellaceae is 
similarly less abundant later in infancy (>8 months chronological age) in preterm infants 
compared to near-term infants (p<1×10−10, Wilcoxon). Despite these differences, we 
observed predicted microbiota functional stability both over time and between groups (Fig. 
1c), as inferred by HUMAnN243. While it is likely that greater variation exists when finer 
functional category or predicted hosts of functions are taken into account, the invariability of 
microbiota functional capacity at this high level suggests that while prematurity, early life 
hospitalization, and antibiotic treatment drastically perturb taxonomic composition of the 
microbiota, a core set of microbial functions remains conserved across hosts44.
Low gut microbiota diversity is often associated with adverse health in infants45–47, 
children5, and adults48. To identify features associated with microbiota diversity, we 
regressed Shannon diversity on clinical variables (Methods, Supplementary Table 1) using a 
generalized linear mixed model with subject defined as individual effect. All variables in 
Supplementary Table 1 were included in initial modeling, and a final model was fit via 
backwards elimination of variables. After correcting for multiple comparisons, day of life 
was significantly associated with increased Shannon diversity (p<0.001), while recent 
(within 30 days of sample collection) administration of vancomycin (p<0.001), ampicillin 
(p<0.001), meropenem (p=0.009), or cefepime (p=0.012) was significantly associated with 
decreased diversity (Fig. 1d). No clinical variable included in the model other than antibiotic 
treatment was significantly associated with IGM diversity. The sparse model explained 57% 
Gasparrini et al. Page 3
Nat Microbiol. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of the variance in Shannon diversity by the fixed effects (day of life and antibiotic 
treatments) alone, and an additional 12% by subject. The magnitude of the model estimate 
for day of life (0.002) was substantially less than those for recent antibiotics (vancomycin, 
−0.34; ampicillin, −0.60; meropenem, −0.42; cefepime, −0.46; oxacillin, −0.70). Thus, a 
single recent course of antibiotics has an effect on diversity of the same magnitude as the 
diversity increase observed over ~5–12 months of life. Across all infants in our cohort 
through the first 110 days of life, Shannon diversity of the microbiota was significantly 
lower in infants who received >1 course of antibiotics in the prior month (Fig. 1e). 
Accordingly, recent antibiotic treatment appears to be a key driver of microbiota diversity 
early in life.
Partial microbiota recovery following NICU discharge
While the taxonomic composition of the preterm infant microbiota clustered by both 
gestational age at birth and antibiotic treatment status (Adonis, p<0.001, Bray–Curtis), 
chronological age was a major driver of microbiota composition across all infants (Fig. 2a). 
We hypothesized that after observed early-life perturbation, the composition of the preterm 
microbiota would converge towards that of age-matched healthy, antibiotic-naïve, near-term 
infants within the first 21 months of life, but that microbiota ‘scars’ from this early-life 
disruption (e.g., enriched ARGs and MDROs) would persist.
To quantify the extent of this perturbation, we used random forests to regress the relative 
abundances of species in the microbiota of infants against their chronological age as 
previously described51. The minimum number of variables required for accurate prediction 
was 50 (Fig. 2b). We trained a model consisting of the 50 most informative predictors on the 
antibiotic-naïve, near-term infant subset to model healthy microbiota development, and 
subsequently refined and validated the model. The top age discriminatory taxa in the IGM of 
antibiotic-naïve, near-term infants were Faecalibacterium prausnitzii, Subdoligranulum sp., 
Ruminococcus gnavus, and Oscillobacter sp. (Fig. 2c). We used this sparse model to predict 
infant chronological age using the relative abundance of these 50 species. This prediction, or 
‘microbiota age,’ approximates relative microbiota maturity51. We observed a linear 
relationship between the chronological and microbiota ages of antibiotic-naïve, near-term 
infants, suggesting that the model accurately predicts near-term infant age. For preterm 
infants, however, predicted microbiota ages were younger than chronological age across 
several stages of development, indicating that microbiota development is disrupted in these 
infants. To better quantify the extent of disruption, we computed a microbiota for age Z-
score (MAZ) for each metagenome, as previously described51. Using a Z-score to compare 
age bins is necessary because this value reflects the variance of predicted age across infant 
microbiota development. Preterm infants who receive antibiotic treatment have significantly 
lower MAZs than near-term infants in the first months of life (Fig. 2e). However, by months 
12–15 of life, the MAZs of hospitalized preterm infants closely resemble those of healthy, 
antibiotic-naïve, near-term infants (Fig. 2f). Thus, despite transient delays in the 
development of the preterm IGM, the bacterial taxonomic composition converges on 
common structures with those of healthy, antibiotic-naïve, infants within the first 21 months 
of life (Fig. 2d).
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Antibiotic resistome of preterm IGM
We next characterized the antibiotic resistome encoded in the IGM of our cohort. We 
conducted functional metagenomic analysis53 of 217 preterm and term infant stools, selected 
to encompass the diversity in clinical variables in our cohort. We constructed 22 functional 
metagenomic libraries totaling 396 gigabase pairs (Supplementary Fig. 4; Supplementary 
Table 1; see Methods) with an average insert size of 2–3 kilobase pairs, selected libraries on 
sixteen antibiotics relevant to infants and children (Supplementary Table 3), and recovered 
resistant transformants for each antibiotic except meropenem (Supplementary Fig. 4). We 
found that the infant gut metagenome encoded transferrable resistance even to antibiotics 
rarely or never used in neonates, such as ciprofloxacin and chloramphenicol, and those that 
represent last lines of defense against MDROs, such as tigecycline and colistin. Only one of 
eight libraries constructed from stools of antibiotic-naïve, near-term infants encoded 
ciprofloxacin resistance (mediated by loci other than gyrA or parC), compared to six out of 
fourteen libraries constructed from preterm infant stools. This observation, given the scarce 
use of ciprofloxacin in neonates28, suggests either that acquired ciprofloxacin resistance 
occurs naturally in preterm infant gut bacterial communities, or that organisms resistant to 
ciprofloxacin are co-selected by other antibiotics to which they are resistant.
We sequenced resistance-conferring metagenomic inserts and assembled 874 unique ARGs. 
The median identity of these functionally-selected ARGs to the NCBI nr database was 
94.4%, while their median identity to the Comprehensive Antibiotic Resistance Database 
(CARD)54 was 32.0% (Fig. 3a). Hence, while most resistance determinants discovered in 
our functional selections have been previously sequenced, they have frequently not been 
assigned resistance functions, a discordance we have previously noted34. Functionally-
selected ARGs with low identity to CARD, while not canonical resistance genes widespread 
in the clinical setting at this point, represent candidates for or progenitors of clinical 
resistance genes given opportunity, mobilization, or evolution53,58. The predicted sources of 
resistance conferring ORFs (determined by best BLAST hit to the NCBI non-redundant 
protein database) were predominantly uncultured bacteria or Enterobacteriaceae (Fig. 3b). 
The identification of Enterobacteriaceae as likely hosts of ARGs in the IGM is consistent 
with current understanding of Enterobacteriaceae as prolific hosts and traffickers of 
ARGs55–57. Additionally, the identification of uncultured (189 ORFs) and unclassified (24 
ORFs) bacteria as sources of ARGs highlights the value of functional metagenomics as a 
culture- and sequence-unbiased method for characterizing resistomes58.
Highlighting the potential for lateral ARG exchange within the infant microbiome, 225 
contigs (6.4% of all contigs) recovered in functional selections encoded a mobile genetic 
element (MGE, Supplementary Fig. 5a–e). MGEs were most commonly observed in 
tetracycline selections (Supplementary Fig. 5f), but were also commonly observed in β-
lactam, chloramphenicol, gentamicin, and ciprofloxacin selections. We observed enrichment 
for MGEs on amoxicillin/clavulanate (p<0.01, hypergeometric test), tetracycline (p<0.01, 
hypergeometric test), and gentamicin (p<0.001, hypergeometric test). The synteny of 
functionally-selected ARGs with MGEs suggests the possibility of a mobilizable resistome 
in the IGM.
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We extended our resistome analysis using ShortBRED59 to quantify translated ARG 
abundance in all sequenced metagenomes with a custom database that included all ARGs 
from CARD as well as functionally-selected ARGs identified here. Resistomes clustered 
according to gestational age at birth and antibiotic treatment status (Fig. 3c, p<0.001, 
Adonis). The gut metagenomes of preterm infants encoded fewer unique ARGs than those of 
near-term infants (p<0.01, Wilcoxon, Fig. 3d). However, the cumulative resistome relative 
abundance was significantly higher in the IGM of preterm infants with early-plus-
subsequent antibiotic treatment compared to preterm infants with early-only antibiotic 
treatment and to antibiotic-naïve, near-term infants (p<0.05, Wilcoxon, Fig. 3e). There was a 
weak inverse correlation between taxonomic alpha diversity and cumulative resistome 
burden across all metagenomes (R2=0.09, Supplementary Fig. 6a), indicating that resistome-
enriched microbiota are dominated by a few species. Indeed, in 41 of the 54 metagenomes 
with a cumulative resistome of reads per kilobase per million mapped reads (RPKM) >5000, 
a single species comprised >50% of microbiota relative abundance. In 25 of these samples, 
the dominant species was E. coli (Supplementary Fig. 6b). Other dominant species were 
Enterococcus faecalis (n=5), Klebsiella pneumoniae (n=2), Staphylococcus epidermidis 
(n=2), Enterobacter aerogenes (n=2), Bifidobacterium breve (n=2), Pseudomonas 
aeruginosa, Bifidobacterium longum, and Citrobacter koseri (n=1 each). Thus, it appears 
that extreme prematurity, associated hospitalization, and antibiotic treatment select for one 
or two MDROs that dominate the IGM rather than enriching for a greater diversity of 
resistant organisms.
To define the developmental progression of the infant gastrointestinal resistome over the first 
months of life, we regressed the abundance of ARGs in a subset of antibiotic-naïve, near-
term infant gut metagenomes against the day of life for these infants using random forests52. 
We constructed a sparse model using the 50 most informative ARGs. The sparse model was 
subsequently applied to preterm samples to predict ‘resistome age.’ A clear developmental 
trajectory based on these 50 ARGs was evident in near-term infants (Fig. 3g). The 
developmental trajectory of the preterm infant gut resistome deviates from that of the 
antibiotic-naïve, near-term infants in prolonged carriage of some ARGs (e.g., oqxA, oqxB, 
catI, fosA5, cdeA), near absence of others (e.g., abeM), and a general increase in the 
normalized abundance of these genes in the gut across all timepoints (Fig. 3g). Overall, we 
found that the model only modestly predicted the chronological age of preterm infants (R2 = 
0.62, Fig. 3f), suggesting that distinct patterns of resistome development emerge based on 
antibiotic treatment status and gestational age at birth.
Persistence of multidrug resistant Enterobacteriaceae in the preterm IGM
Whole metagenome shotgun sequencing is a powerful method for describing gross 
microbiota composition and function but is less well equipped to elucidate strain level 
variation. The gut has been established as an early reservoir of bacteria that cause late onset 
bloodstream infections in neonates60 and is dominated by multidrug resistant (MDR) 
Proteobacteria34, but the extent to which these early colonizing strains persist in the IGM is 
poorly defined. We hypothesized that early life hospitalization and antibiotic treatment in 
preterm infants might create a gastrointestinal niche for such Proteobacteria that is not 
relinquished after discharge from the NICU. To better understand the persistence of specific 
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bacterial strains in the microbiota of infants in our cohort, we cultured pairs of stools 
collected 8–10 months apart from 15 infants (nine preterm and six near-term) on a series of 
selective agars (see Methods). We optimized culture conditions to isolate opportunistic 
extraintestinal pathogens known to be highly prevalent and abundant in the IGM as well as 
those that are frequently MDR. In total, we cultured 530 isolates from these 30 samples. We 
whole genome sequenced, assembled, and annotated 277 and 253 isolates from the preterm 
and near-term sets, respectively.
The species most frequently isolated by this direct selection were E. coli (n=139), K. 
pneumoniae (n=62), E. faecalis (n=50), Enterobacter cloacae (n=42), E. faecium (n=22), C. 
freundii (n=15), and K. oxytoca (n=14). We identified within-infant persistence of nearly 
identical strains of E. coli, E, cloacae, and K. variicola in samples collected from both 
preterm and near-term infants. These highly similar, persistent isolate pairs from preterm 
infants included isolates from samples collected both while in the NICU and following 
discharge (Fig. 4). Among the persistent isolates recovered were strains of E. coli ST405 and 
E. cloacae ST108, both of which are high-risk lineages known to encode extended-spectrum 
β-lactamases and NDM-family carbapenemases61–63. Each of the E. coli strains encoded a 
TEM-1 β-lactamase as well as an aac(3)-IId aminoglycoside acetyltransferase with predicted 
resistance to aminoglycosides, and each E. cloacae strain encoded an AmpC type β-
lactamase. The K. variicola strains each encoded oqxAB, the RND-type multidrug efflux 
pump64, and the chromosomal Klebsiella β-lactamase blaOKP-B-165 (Supplementary Table 
4). We isolated nearly identical MDR Enterobacteriaceae, as suggested by average 
nucleotide identity >99.997% (Fig. 4b,d,f) and core gene single nucleotide polymorphism 
distances (Supplementary Table 4), from the preterm IGM both in the NICU and following 
discharge. These data support an enduring and transmissible pathological microbiome “scar” 
associated with preterm birth, early life hospitalization, and antibiotic treatment.
Because Enterococcus species are prevalent and abundant in the preterm infant gut34, often 
MDR66, and cause nosocomial blood stream infections in preterm infants67, we investigated 
their resistance and virulence phenotypes. A particular concern among hospitalized 
populations is vancomycin resistant Enterococci (VRE)68. Of the 15 unique Enterococcus 
strains we isolated, ten were E. faecalis and five were E. faecium (Supplementary Fig. 7a). 
No E. faecalis, and two E. faecium isolates were resistant to vancomycin. However, no E. 
faecium strain formed a biofilm, while four of the E. faecalis strains formed robust biofilms 
at room temperature, and an additional six formed biofilms at 37˚C (Supplementary Fig. 7b). 
Interestingly, all biofilm forming strains were isolated from preterm infant stool. This is 
consistent with the prevailing understanding that early colonizers of the preterm infant gut 
are largely surface adapted strains that are prevalent in the NICU environment69. E. faecalis 
biofilm formers, while susceptible to vancomycin when planktonic, were resistant to this 
antibiotic when in biofilms (Supplementary Fig. 7c). Thus, despite the apparent tradeoff 
between vancomycin resistance and biofilm formation observed among Enterococcus 
strains, nearly all have evolved strategies for surviving vancomycin treatment. This is 
concerning given widespread usage of vancomycin (Table 1) and prevalence of 
Enterococcus colonization (Fig. 1b) in the NICU.
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Persistent metagenomic signature of antibiotic treatment in premature 
infants
To understand if prematurity, hospitalization, and antibiotic treatment have persistent effects 
on gut microbial content and function, we sought to identify metagenomic features that 
distinguish post-NICU discharge samples in preterm infants from age-matched samples from 
antibiotic-naïve, near-term infants. We used a supervised learning approach to classify 
samples as originating from a hospitalized preterm infant (including both early-only and 
early-plus-subsequent antibiotic treatment groups) or an antibiotic-naïve near-term infant 
residing at home, based on the relative abundance of bacterial taxa and ARGs in their IGM. 
Using a support vector machine, we identified the fifteen most informative features and 
constructed a model consisting of only these variables, which correctly classified all preterm 
and 15 of the 17 near-term samples (96.4% accuracy, Fig. 5a). Of the fifteen variables most 
important to model performance, six were ARGs and nine were bacterial taxa (Fig. 5b). The 
ARGs important to classification were the class A β-lactamase cfxA670, and five genes 
functionally selected on piperacillin or tetracycline, respectively. The highest identity 
BLAST hit of four of the functionally-selected ARGs was an ABC transporter, while the 
other was a MATE family efflux transporter. The predictive species were members of the 
order Clostridiales (Eubacterium rectale, Ruminococcus obeum, R. lactaris, Dorea 
formicigenerans, E. ventriosum, E. ramulus, E. eligens) and Bacteroidales (Prevotella copri, 
Barnesiella intestinihominis). Our model accurately identified if a preterm infant was 
hospitalized and received early life antibiotic treatment based on metagenome composition 
following NICU discharge despite high level architectural recovery.
Conclusion
By combining metagenomic sequencing, selective and differential stool culture paired with 
isolate sequencing, functional metagenomics, and machine learning, we demonstrate 
persistent metagenomic signatures of early life antibiotic treatment and hospitalization in 
preterm infants. This is manifest in an enriched gut resistome and persistent carriage of 
MDR Enterobacteriaceae, despite apparent recovery in microbiota maturity. Regardless of 
prematurity or antibiotic exposure, we observed little variation in the functional capacity of 
the microbiota, albeit when metagenomic reads are binned in broad functional categories. 
Our work highlights the need to integrate sequencing- and culture-based approaches for 
interrogating microbiota to reveal underappreciated effects of perturbations. These 
complementary methods provide data supporting a persistent metagenomic signature of 
early life hospitalization and antibiotic treatment associated with prematurity in the dynamic 
microbial community housed in the infant gut.
We were unable to isolate the effects of antibiotics from those of other adverse early life 
events coinciding with prematurity, such as extended hospitalization and illness. While an 
interventional study to probe these variables in neonates is infeasible, future animal studies 
could provide important insights into their relative contributions. Additionally, it is probable 
that yet to be defined environmental variables play a role in the co-development of the 
immune system and the microbiota, which would need to be addressed in future studies. 
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Despite these caveats, we supply compelling evidence for the underappreciated lasting effect 
of prematurity and associated hospitalization and antibiotic treatment on the microbiome. 
These perturbations may play a role in chronic pathologies associated with prematurity for 
which the etiology is unclear. From a clinical standpoint, our findings emphasize a necessity 
for alternatives to broad-spectrum antimicrobial therapy for managing infection in the 
NICU. This should entail therapeutic approaches such as narrow-spectrum antibiotics and 
probiotic therapies71, but also improved accuracy and speed of diagnostics to reduce 
unnecessary courses of antibiotics. It is unclear if these results are generalizable across 
NICUs. Future multicenter studies are important to reveal the effect of neonatal antibiotic 
stewardship practices in IGM development. While the metagenomic scars we identified may 
be implicated in sequelae of preterm birth such as neurodevelopmental72–74, metabolic75,76, 
cardiac77,78, and respiratory79,80 defects, further experiments with model systems including 
gnotobiotic animals are needed to link these enduring dysbioses and lasting pathologies.
Methods
Sample and metadata collection
All samples and patient metadata used in this study were collected as part of the Neonatal 
Microbiome and Necrotizing Enterocolitis Study (P.I.T., P.I.) or the St. Louis Neonatal 
Microbiome Initiative (B.B.W., P.I.) at Washington University School of Medicine and 
approved by the Human Research Protection Office (approval numbers 201105492 and 
201104267, respectively). Samples were obtained from infants after parents provided 
informed consent. Because very few hospitalized preterm infants are antibiotic naïve, we 
stratified our cohort for sample analysis by antibiotic exposure and gestational age at birth, 
with a subset of individuals with early antibiotic exposure only (N=9) with no antibiotic 
exposure outside the first week of life, a subset of individuals with early and subsequent 
antibiotic exposure (N=32), and a subset of late preterm or early term infants (N=17) who 
were not hospitalized and were antibiotic-naïve over the first months of life (Table 1). All 
stools produced were collected and stored as previously described1,2. In total, 437 samples 
collected longitudinally from 58 infants were shotgun sequenced and included in all 
metagenomic analysis.
Metagenomic DNA extraction
Metagenomic DNA was extracted from approximately 100 mg of stool samples using the 
PowerSoil DNA Isolation Kit (MoBio Laboratories) following the manufacturer’s protocol 
with the following modification: samples were lysed by two rounds of two minutes of bead 
beating at 2.5k oscillations per minute for 2 minutes followed by 1 minute on ice and 2 
additional minutes of beadbeating using a Mini-Beadbeater-24 (Biospec Products). DNA 
was quantified using a Qubit fluorometer dsDNA BR Assay (Invitrogen) and stored at 
−20˚C.
Metagenomic sequencing library preparation
Metagenomic DNA was diluted to a concentration of 0.5 ng/μL prior to sequencing library 
preparation. Libraries were prepared using a Nextera DNA Library Prep Kit (Illumina) 
following the modifications described in Baym et al, 20153. Libraries were purified using 
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the Agencourt AMPure XP system (Beckman Coulter) and quantified using the Quant-iT 
PicoGreen dsDNA assay (Invitrogen). For each sequencing lane, 10 nM of approximately 96 
samples were pooled three independent times. These pools were quantified using the Qubit 
dsDNA BR Assay and combined in an equimolar fashion. Samples were submitted for 
2×150 bp paired-end sequencing on an Illumina NextSeq High-Output platform at the 
Center for Genome Sciences and Systems Biology at Washington University in St. Louis 
with a target sequencing depth of 2.5 million reads per sample.
Rarefaction analysis
To determine the appropriate sequencing depth necessary to fully characterize infant gut 
microbiota composition and function, 17 representative metagenomes that were sequenced 
most deeply were subsampled at the following read depths: 8000000, 7000000, 6000000, 
5000000, 4000000, 3000000, 2000000, 1000000, 100000, and 10000. Subsampled 
metagenomes were profiled using MetaPhlAn 2.04 to determine species richness at each 
depth. Rarefaction was only used to establish an appropriate sequencing depth, and 
subsampled metagenomes were not used for any downstream analyses.
Metagenome profiling
Prior to all downstream analysis, Illumina paired-end reads were binned by index sequence. 
Adapter and index sequences were trimmed and sequences were quality filtered using 
Trimmomatic v0.365 using the following parameters: java -Xms2048m -Xmx2048m -jar 
trimmomatic-0.33.jar PE -phred33 ILLUMINACLIP: NexteraPE-PE.fa:2:30:10:1:true 
SLIDINGWINDOW:6:10 LEADING:13 TRAILING:13 MINLEN:36. Relative abundance 
of species was calculated using MetaPhlAn 2.04 (repository tag 2.2.0). Relative abundance 
tables were merged using the merge_metaphlan_tables.py script. Abundance of metabolic 
pathways was determined using HUMAnN26. Raw count values were normalized for 
sequencing depth, collapsed by ontology, and tables were merged using the 
humann2_renorm_table, humann2_regroup_table, and humann2_join_tables utility scripts.
Construction of metagenomic libraries from infant gut samples for functional selection
We constructed 22 functional metagenomic libraries by pooling metagenomic DNA from 9–
10 stools per library, encompassing 396 gigabase pairs (Gb) of metagenomic DNA with an 
average library size of 18 Gb (Supplementary Fig. 4; Supplementary Table 1) and an average 
insert size of 2–3 kilobase pairs (kb). Approximately 5 μg purified extracted total 
metagenomic DNA was used as starting material for metagenomic library construction. To 
create small-insert metagenomic libraries, DNA was sheared to a target size of 3,000bp 
using the Covaris E210 sonicator following manufacturer’s recommended settings (http://
covarisinc.com/wp-content/uploads/pn_400069.pdf). Sheared DNA was concentrated by 
QIAquick PCR Purification Kit (Qiagen) and eluted in 30 μl nuclease-free H2O. Then the 
purified DNA was size-selected by using BluePippin instrument (Sage Science) to a range of 
1000–6000 bp DNA fragment through a premade 0.75% Pippin gel cassette. Size selected 
DNA was then end-repaired using the End-It DNA End Repair kit (Epicentre) with the 
following protocol
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1. Mix the following in a 50 μl reaction volume: 30 μl of purified DNA, 5 μl dNTP 
mix (2.5 mM), 5 μl 10X End-Repair buffer, 1 μl End-Repair Enzyme Mix and 4 
μl nuclease-free H2O.
2. Mix gently and incubate at room temperature for 45 min.
3. Heat-inactivate the reaction at 70°C for 15 min.
End-repaired DNA was then purified using the QIAquick PCR purification kit (Qiagen) and 
quantified using the Qubit fluorometer BR assay kit (Life Technologies) and ligated into the 
pZE21-MCS-1 vector at the HincII site. The pZE21 vector was linearized at the HINCII site 
using inverse PCR with PFX DNA polymerase (Life Technologies)
1. Mix the following in a 50 μl reaction volume: 10 μl of 10X PFX reaction buffer, 
1.5 μl of 10 mM dNTP mix (New England Biolabs), 1 μl of 50 mM MgSO4, 5 μl 
of PFX enhancer solution, 1 μl of 100 pg μl 21 circular pZE21, 0.4 μl of PFX 
DNA polymerase, 0.75 μl forward primer (5’ GAC GGT ATC GAT AAG CTT 
GAT 3’), 0.75 μl reverse primer (5’ GAC CTC GAG GGG GGG 3’) and 29.6 μl 
of nuclease free H2O to a final volume of 50 μl.
2. PCR cycle temperature as follows: 95°C for 5 min, then 35 cycles of [95°C for 
45 s, 55°C for 45 s, 72°C for 2.5 min], then 72°C for 5 min.
Linearized pZE21 was size-selected (~2,200bp) on a 1% low melting point agarose gel 
(0.5X TBE) stained with GelGreen dye (Biotium) and purified by QIAquick Gel Extraction 
Kit (Qiagen). Pure vector was dephosphorylated using calf intestinal alkaline phosphatase 
(CIP, New England BioLabs) by adding 1/10th reaction volume of CIP, 1/10th reaction 
volume of New England BioLabs Buffer 3, and nuclease-free H2O to the vector elute and 
incubating at 37°C overnight before heat inactivation from 15 min at 70°C. End-repaired 
metagenomic DNA and linearized vector were ligated together using the Fast-Link Ligation 
Kit (Epicentre) at a 5:1 ratio of insert:vector using the following protocol
1. Mix the following in a 15 μl reaction volume: 1.5 μl 10X Fast-Link buffer, 0.75 
μl ATP (10 mM), 1 μl FastLink DNA ligase (2 U/μl), 5:1 ratio of metagenomic 
DNA to vector, and nuclease-free H2O to final reaction volume.
2. Incubate at room temperature overnight.
3. Heat inactivate for 15 min at 70°C.
After heat inactivation, ligation reactions were dialyzed for 30 min using a 0.025 um 
cellulose membrane (Millipore catalogue number VSWP09025) and the full reaction volume 
used for transformation by electroporation into 25 μl E. coli MegaX (Invitrogen) according 
to manufacturer’ srecommended protocols (http://tools.invitrogen.com/content/sfs/manuals/
megax_man.pdf). Cells were recovered in 1 ml Recovery Medium (Invitrogen) at 37°C for 
one hour. Libraries were titered by plating out 0.1 μl and 0.01 μl of recovered cells onto 
Luria–Bertani (LB) agar plates containing 50 μg/ml kanamycin. For each library, insert size 
distribution was estimated by gel electrophoresis of PCR products obtained by amplifying 
the insert from 36 randomly picked clones using primers flanking the HincII site of the 
multiple cloning site of the pZE21 MCS1 vector (which contains a selectable marker for 
kanamycin resistance). The average insert size across all libraries was determined to be 3 kb, 
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and library size estimates were calculated by multiplying the average PCR-based insert size 
by the number of titered colony forming units (CFUs) after transformation recovery. The rest 
of the recovered cells were inoculated into 50 ml of LB containing 50 μg/ml kanamycin and 
grown overnight. The overnight culture was frozen with 15% glycerol and stored at −80°C 
for subsequent screening.
Functional selections for antibiotic resistance
Each metagenomic library was selected for resistance to each of 16 antibiotics (at 
concentrations listed in Supplementary Table 3 plus 50 μg/ml kanamycin for plasmid library 
maintenance) was performed using LB agar. Of note, as our library host, E. coli, is 
intrinsically resistant to vancomycin, we are unable to functionally screen for loci conferring 
resistance to this antibiotic. Further, the use of kanamycin as the selective marker for the 
metagenomic plasmid library results in low-level cross-resistance with other aminoglycoside 
antibiotics, resulting in a higher required minimum inhibitory concentration for gentamicin. 
For each metagenomic library, the number of cells plated on each antibiotic selection 
represented 10x the number of unique CFUs in the library, as determined by titers during 
library creation. Depending on the titer of live cells following library amplification and 
storage, the appropriate volume of freezer stocks were either diluted to 100 μl using MH 
broth + 50 μg/ml kanamycin or centrifuged and reconstituted in this volume for plating. 
After plating (using sterile glass beads), antibiotic selections were incubated at 37°C for 18 
hours to allow the growth of clones containing an antibiotic resistance conferring DNA 
insert. Of the 352 antibiotic selections performed, 296 yielded antibiotic-resistant E. coli 
transformants (Supplementary Fig. 4). After overnight growth, all colonies from a single 
antibiotic plate (library by antibiotic selection) were collected by adding 750 μl of 15% LB-
glycerol to the plate and scraping with an L-shaped cell scraper to gently remove colonies 
from the agar. The slurry was then collected and this process was repeated a second time for 
a total volume of 1.5 mL to ensure that all colonies were removed from the plate. The 
bacterial cells were then stored at −80°C before PCR amplification of antibiotic-resistant 
metagenomic fragments and Illumina library creation.
Amplification and sequencing of functionally-selected fragments
Freezer stocks of antibiotic-resistant transformants were thawed and 300 μl of cells pelleted 
by centrifugation at 13,000 revolutions per minute (r.p.m.) for two minutes and gently 
washed with 1 mL of nuclease-free H2O. Cells were subsequently pelleted a second time 
and re-suspended in 30 μl of nuclease-free H2O. Re-suspensions were then frozen at −20°C 
for one hour and thawed to promote cell lysis. The thawed re-suspension was pelleted by 
centrifugation at 13,000 r.p.m. for two minutes and the resulting supernatant was used as 
template for amplification of resistance-conferring DNA fragments by PCR with Taq DNA 
polymerase (New England BioLabs)
1. Mix the following for a 25 μl reaction volume: 2.5 μl of template, 2.5 μl of 
ThermoPol reaction buffer (New England BioLabs), 0.5 μl of 10 mM 
deoxynucleotide triphosphates (dNTPs, New England Biolabs), 0.5 μl of Taq 
polymerase (5 U/μl), 3 μl of a custom primer mix, and 16 μl of nuclease-free 
H2O.
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2. PCR cycle temperature as follows: 94°C for 10 min, then 25 cycles of [94°C for 
45 s, 55°C for 45 s, 72°C for 5.5 min], then 72°C for 10 min.
The custom primer mix consisted of three forward and three reverse primers, each targeting 
the sequence immediately flanking the HincII site in the pZE21 MCS1 vector, and staggered 
by one base pair. The staggered primer mix ensured diverse nucleotide composition during 
early Illumina sequencing cycles and contained the following primer volumes (from a 10 
mM stock) in a single PCR reaction: (primer F1, CCGAATTCATTAAAGAGGAGAAAG, 
0.5 μl); (primer F2, CGAATT CATTAAAGAGGAGAAAGG, 0.5 μl); (primer F3, 
GAATTCATTAAAGAGGAGAAAGGTAC, 0.5 μl); (primer R1, 
GATATCAAGCTTATCGATACCGTC, 0.21 μl); (primer R2, 
CGATATCAAGCTTATCGATACCG, 0.43 μl); (primer R3, 
TCGATATCAAGCTTATCGATACC, 0.86 μl). The amplified metagenomic inserts were then 
cleaned using the Qiagen QIAquick PCR purification kit and quantified using the Qubit 
fluorometer HS assay kit (Life Technologies).
For amplified metagenomic inserts from each antibiotic selection, elution buffer was added 
to PCR template for a final volume of 200 μl and sonicated in a half-skirted 96-well plate on 
a Covaris E210 sonicator with the following setting: duty cycle, 10%; intensity, 5; cycles per 
burst, 200; sonication time, 600s. Following sonication, sheared DNA was purified and 
concentrated using the MinElute PCR Purification kit (Qiagen) and eluted in 20 μl of pre-
warmed nuclease-free H2O. In the first step of library preparation, purified sheared DNA 
was end-repaired
1. Mix the following for a 25 μl reaction volume: 20 μl of elute, 2.5 μl T4 DNA 
ligase buffer with 10 mM ATP (10X, New England BioLabs), 1 μl dNTPs (1 
mM, New England BioLabs), 0.5 μl T4 polymerase (3 U/μl, New England 
BioLabs), 0.5 μl T4 PNK (10 U/μl, New England BioLabs), and 0.5 μl Taq 
Polymerase (5 U/μl, New England BioLabs).
2. Incubate the reaction at 25°C for 30 min followed by 20 min at 75°C.
Next, to each end-repaired sample, 5 μl of 1 μM pre-annealed, barcoded sequencing adapters 
were added (adapters were thawed on ice). Barcoded adapters consisted of a unique 7-bp 
oligonucleotide sequence specific to each antibiotic selection, facilitating the de-
multiplexing of mixed-sample sequencing runs. Forward and reverse sequencing adapters 
were stored in TES buffer (10 mM Tris, 1 mM EDTA, 50 mM NaCl, pH 8.0) and annealed 
by heating the 1 μM mixture to 95°C followed by a slow cool (0.1°C per second) to a final 
holding temperature of 4°C. After the addition of barcoded adapters, samples were 
incubated at 16°C for 40 min and then for 10 min at 65°C. Before size-selection, 10 μl each 
of adapter-ligated samples were combined into pools of 12 and concentrated by elution 
through a MinElute PCR Purification Kit (Qiagen), eluting in 14 μl of elution buffer (10 mM 
Tris-Cl, pH 8.5). The pooled, adaptor-ligated, sheared DNA was then size-selected to a 
target range of 300–400 bp on a 2% agarose gel in 0.5X TBE, stained with GelGreen dye 
(Biotium) and extracted using a MinElute Gel Extraction Kit (Qiagen). The purified DNA 
was enriched using the following protocol
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1. Mix the following for a 25 μl reaction volume: 2 μl of purified DNA, 12.5 μl 2X 
Phusion HF Master Mix (New England BioLabs), 1 μl of 10 mM Illumina PCR 
Primer Mix (5’-AAT GAT ACG GCG ACC ACC GAG ATC-3’ and 5’-
CAAGCAGA A GAC GGC ATA CGA GAT-3’), and 9.5 μl of nuclease-free 
H2O.
2. PCR cycle as follows: 98°C for 30 s, then 18 cycles of [98°C for 10s, 65°C for 
30 s, 72°C for 30s], then 72°C for 5 min.
Amplified DNA was measured using the Qubit fluorometer HS assay kit (Life Technologies) 
and 10 nM of each sample were pooled for sequencing. Subsequently, samples were 
submitted for paired-end 101-bp sequencing using the Illumina Next Seq platform at the 
DNA Sequencing and Innovation Lab at the Edison Center for Genome Sciences and 
Systems Biology, Washington University in St Louis, USA). In total, three sequence runs 
were performed at 10 pM concentration per lane.
Assembly and annotation of functionally-selected fragments
Illumina paired-end sequence reads were binned by barcode (exact match required), such 
that independent selections were assembled and annotated in parallel. Assembly of the 
resistance-conferring DNA fragments from each selection was achieved using PARFuMS7 
(Parallel Annotation and Reassembly of Functional Metagenomic Selections), a tool 
developed specifically for the high-throughput assembly and annotation of functional 
metagenomic selections.
Open reading frames (ORFs) were predicted in assembled contigs using MetaGeneMark8 
and annotated by searching amino acid sequences against Pfam, TIGRfam, and an ARG 
specific profile hidden Markov model (pHMM) database, Resfams9 (http://
www.dantaslab.org/resfams), with HMMER310. MetaGeneMark was run using default gene-
finding parameters while hmmscan (HMMER3) was run with the option --cut_ga as 
implemented in the script annotate_functional_selections.py. Selections were excluded from 
analysis if (a) more than 200 contigs were assembled or (b) the number of contigs assembled 
exceeded the number of colonies on the selection plate by a factor of ten. Further, assembled 
contigs less than 500 bp were discarded. Since many assembled contigs include multiple 
annotated ORFs, the subset of proteins considered causative resistance determinants for 
downstream analysis were classified using the following hierarchical scheme. First, if a 
contig encoded a protein with a 100% amino acid identity hit to the CARD database11, it 
was considered the causative resistance determinant on that contig. Next, if a contig encoded 
a protein with a significant hit to a Resfams pHMM using profile specific gathering 
thresholds, it was considered the causative resistance determinant on that contig. In absence 
of a high scoring hit to the CARD or Resfams databases, contigs were manually curated to 
identify plausible resistance determinants on an antibiotic specific basis. The rationale for 
this hierarchical classification scheme was to first identify perfect matches to known 
resistance determinants via BLAST to CARD (with a threshold of 100% amino acid 
identity), and subsequently identify variants of known resistance determinants using 
Resfams pHMMs. Using these criteria, 1184 of the 5658 unique predicted proteins (20.9%) 
were classified as resistance determinants.
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The percent identity of all resistance determinants were determined using BlastP12 query 
against both the NCBI non-redundant protein database (retrieved May 21, 2018) and the 
CARD11 database (version 1.2.1, retrieved January 24, 2018). Once the top local alignment 
was identified with BlastP, it was used for a global alignment using the Needleman-Wunsch 
algorithm as implemented in the needle program of EMBOSS13 version 6.6.0 as previously 
described14.
Putative mobile genetic elements were identified on functionally-selected contigs based on 
string matches to one of the following keywords in Pfam and TIGRfam annotations: 
‘transposase’, ‘transposon’, ‘conjugative’, ‘integrase’, ‘integron’, ‘recombinase’, ‘conjugal’, 
‘mobilization’, ‘recombination’, or ‘plasmid’.
Quantification of antibiotic resistance genes in metagenomes
Relative abundance of antibiotic resistance genes was calculated using ShortBRED31. 
Causative resistance determinants, as identified using the hierarchical annotation scheme 
described above, were used as proteins of interest for identification of marker families using 
shortbred_identify.py. These proteins included all antibiotic resistance genes in CARD 
(version 1.2.1, retrieved January 24, 2018)54 and antibiotic resistance proteins identified 
using functional metagenomic selections performed in the current study. Thus, the custom 
ShortBRED database included markers to canonical antibiotic resistance determinants as 
well as resistance determinants functionally identified in this study which are most relevant 
to the infant gut microbiota. In order to calculate relative abundance of resistance genes in 
metagenomes, shortbred_quantify.py was used.
Bacterial isolation from infant stools
Approximately 50 mg of frozen stool was resuspended in 1 mL Tryptic Soy Broth (TSB) 
and incubated with shaking at 37˚C for four hours. 50 μL of culture was streaked for 
isolation using the four quadrant method on each of the following agars: Bile Esculin Agar, 
ESBL Agar, MacConkey Agar, MacConkey Agar+cefotaxime, MacConkey Agar
+ciprofloxacin, and Blood Agar (Hardy Diagnostics catalog numbers G12, G321, G35, 
G121, G258, A10, respectively). Plates were incubated for 18–24 hours at 37˚C. Four 
colonies of each distinct morphology on each plate were substreaked onto blood agar and 
incubated for 18–24 hours at 37˚C. Following confirmation of morphology, a 1 mL TSB was 
inoculated with a single colony and grown overnight at 37˚C with shaking. Overnight 
cultures were frozen in 15% glycerol in TSB.
Genomic DNA isolation
1.5 mL TSB was inoculated from isolate glycerol stocks and grown overnight at 37˚C with 
shaking. DNA was extracted using the BiOstic Bacteremia DNA Isolation Kit (MoBio 
Laboratories) following manufacturer’s protocols. Genomic DNA was quantified using a 
Qubit fluorometer dsDNA BR Assay (Invitrogen) and stored at −20˚C.
Isolate sequencing library preparation
Isolate sequencing libraries were prepared in the same manner as described for metagenomic 
sequencing libraries, following the protocol described in Baym et al., 2015. For each 
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sequencing lane, 10 nM of approximately 300 samples were pooled three independent times. 
These pools were quantified using the Qubit dsDNA BR Assay and combined in an 
equimolar fashion. Samples were submitted for 2×150 bp paired-end sequencing on an 
Illumina NextSeq High-Output platform at the Center for Genome Sciences and Systems 
Biology at Washington University in St. Louis with a target sequencing depth of 1 million 
paired end reads per sample.
Assembly of isolate genomes
Prior to all downstream analysis, Illumina paired end reads were binned by index sequence. 
Adapter and index sequences were trimmed using Trimmomatic v0.365 using the following 
parameters: java -Xms2048m -Xmx2048m -jar trimmomatic-0.33.jar PE -phred33 
ILLUMINACLIP: NexteraPE-PE.fa:2:30:10:1:true. Contaminating human reads were 
removed using DeconSeq15 and unpaired reads were discarded. Reads were assembled using 
SPAdes16 with the following parameters: spades.py -k 21,33,55,77 –careful. Contigs less 
than 500 bp were excluded from further analysis. Assembly quality was assessed using 
QUAST17. Average coverage across the assembly was calculated by mapping raw reads to 
contigs using bbmap (https://jgi.doe.gov/data-and-tools/bbtools/).
Isolate genomic analysis
A total of 406 assemblies had an N50 greater than 50,000 and fewer than 500 total contigs 
longer than 1000 bp and were included in further analysis. Genomes were annotated using 
Prokka18 with default parameters. Multilocus sequence types were determined using in 
silico MLST (https://github.com/tseemann/mlst). Species assignments were determined by 
querying assemblies against a RefSeq sketch using Mash identifying RefSeq hit with the 
minimum Mash distance19. Assemblies were binned by species according to Mash 
designation. For each of the seven most commonly occurring species, pangenome analysis 
was performed using Roary, with core genome alignments created with PRANK20. An 
outgroup assembly of the same genus but different species was downloaded from NCBI and 
included in each pangenome analysis (Supplementary Table 2). Maximum likelihood core 
genome phylogenies were constructed using RAXML under the GTRGAMMA model with 
1000 bootstraps and maximum likelihood optimization initialized from a random starting 
tree. Average nucleotide identities were computed using pyani (https://github.com/
widdowquinn/pyani). Pairwise single nucleotide polymorphism distances were calculated 
from core genome alignments generated by Roary using snp-dists (https://github.com/
tseemann/snp-dists). Resistance genes were annotated via nucleotide blast to the resfinder 
database (https://bitbucket.org/genomicepidemiology/resfinder/src/master/README.md).
Enterococcus biofilm formation assay
Mid-log phase cultures in freshly-prepared tryptic soy broth containing 0.5% glucose 
(TSBG) were diluted to OD 0.1. 200ul of the diluted culture was added in quadruplicate to 
96 well polystyrene plates and incubated at room temperature or 37˚C without shaking. 
After 24 hours of growth, wells were decanted, washed three times with sterile PBS, and 
fixed for 30 minutes with 200 μl Bouin’s solution. Fixative was removed by washing three 
times with sterile PBS, then wells were stained with 0.1% crystal violet for 30 minutes. 
Excess stain was removed by washing three times with sterile PBS, the stain was solubilized 
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in 200ul ethanol, and absorbance read at 590nm. E. faecalis strains TX5682 (biofilm 
negative) and TX82 (biofilm positive) were used as controls21.
Enterococcus vancomycin susceptibility testing
Isolates identified as Enterococcus were phenotyped for vancomycin resistance using 
microbroth dilution according to the CLSI guidelines. ATCC29212 (vancomycin 
susceptible) and ATCC51299 (vancomycin-resistant) were included in all assays as controls. 
Isolates were grown to mid-log phase, diluted in culture media to 1×106 CFU/ml, and used 
to inoculate plates containing vancomycin ranging from 128–2ug/ml. After 24 hours of 
static growth at 37˚C, optical density was read at 600 nm and MIC was determined by 
scoring by eye for turbidity.
Vancomycin resistance of biofilms was assayed after establishing biofilms as above. After 
24 hours of static growth at 37˚C, planktonic cells were removed by washing three times 
with sterile water, and then 200 μl of TSBG containing 5 mg/ml, 5 μg/ml, or no vancomycin, 
and the plates incubated at 37˚C for an additional 24 hours. After washing planktonic cells 
three times with sterile water, 200 μl sterile water was added to each well and the viability of 
the cells in the biofilm was assessed using an XTT Cell Viability Kit (Cell Signaling 
Technology, #9095) according to manufacturer’s protocols, reading absorbance at 450nm 60 
minutes after addition of reagents.
Generalized linear mixed model of microbiota diversity
To model the effect of clinical variables on microbiota diversity, a generalized linear mixed 
model was fit by maximum likelihood using the lme4 package in R. All variables in 
Supplementary Table 1 were included in initial modeling, and a final model was fit via 
backwards elimination of variables. Pseudo-R2 was determined using r.squaredGLMM 
function in the MuMin package. P values were corrected for multiple hypotheses using the 
glht function in the multcomp (lincfit = mcp(tension = ‘Tukey’)).
Microbiota age regression using Random Forests
Random Forests was used to regress the relative abundances of all species predicted by 
MetaPhlAn2 in infant stool samples against their chronological age using the R package 
“randomForest” as previously described22. The default parameters were used with the 
following exceptions: ntree=10,000, importance=TRUE. Fivefold cross-validation was 
performed using the rfcv function over 100 iterations to estimate the minimum number of 
features needed to accurately predict microbiota age. The features most important for 
prediction were identified over 100 iterations of the importance function, and a sparse model 
consisting of the 50 most important features was constructed and trained on a set of nine 
antibiotic-naïve near-term infants randomly selected from the larger near-term infant set. 
This model was validated in the remaining eight antibiotic-naïve near-term infants, and then 
applied preterm infants to predict microbiota age. Microbiota for age Z-score was computed 
as previously described22. This allowed for comparisons of microbiota maturity between age 
bins as the metric accounts for differing variance in predicted microbiota age throughout 
infant development.
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Classification of post-discharge samples
A single sample from each individual was selected (the final post-discharge sample collected 
from each preterm infant and a roughly age matched sample from each near-term infant). All 
metagenomic data (species and ARG abundances, centered and scaled) were initially used as 
input for logistic regression, k-nearest neighbor, support vector machine, naïve bayes, and 
random forests classifiers. Ultimately, a support vector machine as implemented in the R 
package e1071 was selected as it was both the highest performing and most parsimonious 
classifier. Feature importance was determined by computing the elementwise absolute value 
of the matrix of weights by the matrix of support vectors. A sparse model was subsequently 
constructed consisting of only the fifteen most important features.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1 |. Clinical variables predict microbiota diversity and composition.
a, Shannon diversity of all near-term (n=17) and preterm (n=41) infants in this study, by 
month of life. Box plots represent the first quartile, median, and third quartile of the data 
with whiskers extending to the last data point within 1.5× the interquartile range. b, 
Microbiota species and functional compositions inferred by MetaPhlAn2 of all near-term 
(n=17) and preterm (n=41) infants in this study. c, Microbiota species and functional 
compositions inferred by HUMAnN2 of all near-term (n=17) and preterm (n=41) infants in 
this study. d, Day of life is significantly associated with an increase in microbiota Shannon 
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diversity, while vancomycin, ampicillin, meropenem, or cefepime treatment within the 
month prior to sampling is associated with significantly decreased species richness (***, 
p<0.001, ** p<0.01, * p<0.05; generalized linear mixed model with subject as random effect 
using 437 infant gut metagenomes.) Oxacillin was included in the model but was not 
significant after correction for multiple comparisons. Error bars indicate s.e. e, Shannon 
diversity is significantly lower in infants who have received >1 course of antibiotic treatment 
in the past month compared to infants who had not received antibiotic treatment during that 
time span (**** p<0.0001, ***, p<0.001, ** p<0.01, * p<0.05; two-sided Wilcoxon with 
Benjamini-Hochberg correction, n=212 samples). Box plots represent the first quartile, 
median, and third quartile of the data with whiskers extending to the last data point within 
1.5× the interquartile range.
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Figure 2 |. Partial architectural recovery of preterm infant gut microbiota following discharge 
from NICU.
a, Microbiota composition is distinct between near-term infants, preterm infants with early 
only antibiotic treatment, and preterm infants with early and subsequent antibiotic treatment 
(Bray-Curtis, p<0.001, Adonis, n=437 samples), but chronological day of life (DOL) is a 
major driver of microbiota composition. b, Fivefold cross-validation indicates that 50 
variables are sufficient for random forests prediction of chronological age of near-term 
infants based on microbiota composition. Inset details vertex. Points indicate mean and error 
bars indicate s.e. computed over 100 iterations. c, The 50 most informative predictors to the 
random forests model. These species were included in a sparse model. Points indicate mean 
and error bars indicate s.e. computed over 100 iterations. d, The sparse random forests 
model accurately predicts near-term infant chronological age, but preterm infant 
chronological age is predicted to be less than actual age across numerous stages of 
development. Curves are loess regression fit to each group and shading depicts 95% 
confidence interval, n=437 samples. e, Preterm infant microbiota for age Z-score (MAZ) is 
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significantly lower than that of near-term infants in the first month of life, indicating early 
microbiota immaturity (** p<0.01, **** p<0.0001, two-sided Wilcoxon, n=140 samples). f, 
Preterm infant MAZ is statistically indistinguishable from near-term infant by 12–15 months 
of life, indicating resolution of microbiota immaturity by this time point (p>0.05, two-sided 
Wilcoxon, n=65 samples). Box plots represent the first quartile, median, and third quartile of 
the data with whiskers extending to the last data point within 1.5× the interquartile range.
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Figure 3 |. Preterm infants harbor an enriched gut resistome.
a, Amino acid identity between all functionally-selected ARGs and their top hit in CARD vs 
their top hit in the NCBI nr protein database, colored by class of antibiotic used for 
selection. Notably, ARGs recovered by fluoroquinolone and polymyxin selection have very 
low median identity to CARD. Box plots represent the first quartile, median, and third 
quartile of the data with whiskers extending to the last data point within 1.5× the 
interquartile range, n=879 ARGs. b, The most commonly predicted hosts of functionally-
selected ARGs based on highest identity BLAST hit in the NCBI nr protein database. c, Gut 
resistome composition is distinct between near-term infants, preterm infants with early only 
antibiotic treatment, and preterm infants with early and subsequent antibiotic treatment 
(Bray-Curtis, p<0.001, Adonis, n=437 samples). d, Preterm infants had fewer unique ARGs 
encoded in their gut metagenomes than near-term infants. (* p<0.05, ** p<0.01 two-sided 
Wilcoxon, n=437 samples). Box plots represent the first quartile, median, and third quartile 
of the data with whiskers extending to the last data point within 1.5× the interquartile range. 
e, The cumulative resistome relative abundance was significantly higher in the gut 
microbiota of preterm infants with early and subsequent antibiotic treatment compared to 
both preterm infants with only early antibiotic treatment and near-term infants (* p<0.05, 
two-sided Wilcoxon, n=437 samples). Box plots represent the first quartile, median, and 
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third quartile of the data with whiskers extending to the last data point within 1.5× the 
interquartile range. f, A random forests model trained on preterm infant gut resistome poorly 
predicts chronological age of near-term infants. Black line is linear regression line of day of 
life as predicted by the random forests model against the actual day of life (R2=0.62, n=437 
samples) g, Relative abundance of 50 most informative resistance genes over the first 
months of life in near-term (left heatmap) and preterm (right heatmap) infants. Resistance 
genes are hierarchically clustered and listed to the right of the heatmaps. Colored bars above 
heatmaps correspond to colors in panels c-e. For canonical resistance genes, the CARD 
accession is displayed and for resistance genes functionally-selected in this study, the 
relevant selection information is listed.
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Figure 4 |. Multidrug resistant Enterobacteriaceae lineages persist in infant gut microbiota.
Maximum likelihood core genome phylogenies of E. coli (a), Klebsiella spp. (c), and E. 
cloacae (e) isolated from infant stool. Annotations to the right of metadata indicate 
timepoints of isolation and sequence type (determined by in silico MLST) for E. coli and E. 
cloacae or species for Klebsiella. Persistent isolates are highlighted in red. Average 
nucleotide identity heat maps for E. coli (b), Klebsiella spp. (d), and E. cloacae (f) indicate 
that persistent isolates are isogenic, i.e., they share >99.997% nucleotide identity. Persistent 
isolate pairs are highlighted in red. g, Timeline of isolation of persistent Enterobacteriaceae 
from infant stool. Vertical bar indicates the day at which infants were discharged from the 
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hospital. The first two infants displayed are preterm infants, while the third is a near-term 
infant.
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Figure 5 |. Enduring damage to the preterm infant gut microbiota.
a, Support vector machine confusion matrix for classification of gestational age based on the 
species and ARGs present in the microbiota following discharge from the NICU or at 
matched timepoints in unhospitalized near-term infants. b, Twenty predictors most important 
to classification. A sparse model trained using only these twenty predictors was highly 
accurate (96.4% classification accuracy), a persistent metagenomic signature of preterm 
birth and associated hospitalization and antibiotic treatment.
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Table 1 |
Clinical characteristics of infant cohorts analyzed in this study
Preterm Early Antibiotic 
Exposure Only (N=9)
Preterm Early + 
Subsequent Antibiotic 
Exposure (N=32)
Term Antibiotic-Naïve 
Infants (N=17)
Birth weight, g, median (IQR) 1080 (880, 1270) 830 (698.75, 897.5) 2529 (2359.5, 2966.5)
Gestational age at birth, weeks, median (IQR) 27 (26, 27) 25 (24, 26) 36 (36,37)
Gender, M/F 4/5 15/17 4/13
Route of delivery, C-section/vaginal 6/3 25/7 15/2
Antibiotic exposure, n courses
 Gentamicin 9 74 none
 Ampicillin 9 37 none
 Vancomycin none 67 none
 Clindamycin none 16 none
 Meropenem none 14 none
 Cefepime none 11 none
 Cefotaxime none 10 none
 Mupirocin none 7 none
 Trimethoprim-sulfamethoxazole none 4 none
 Ticarcillin-clavulanate none 3 none
 Oxacillin none 3 none
 Cefoxitin none 3 none
 Cefazolin none 2 none
 Amoxicillin none 2 none
 Metronidazole none 1 none
 Penicillin G none 1 none
Bacterial culture positive, n
 Blood 0 22 0
 Tracheal 0 30 0
 Urine 0 17 0
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